US Patent 7238666 Method of inhibiting fibrosis with a somatostatin agonist
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+266 characters)
Article
Patent abstract
The present invention relates to a method of inhibiting fibrosis in a patient. The method comprises administering a therapeutically effective amount of a somatostatin, a somatostatin agonist or apharmaceutically acceptable salt thereof to said patent.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07238666 Method of inhibiting fibrosis with a somatostatin agonist US Patent 7238666 Method of inhibiting fibrosis with a somatostatin agonist
Infobox
Patent Number
0723866600
Patent Number
723866600
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072386660
Date of Patent
July 3, 2007
0Patent Application Number
109355930
Date Filed
September 7, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072386660
Date of Patent
July 3, 2007
0Patent Application Number
109355930
Date Filed
September 7, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07238666 Method of inhibiting fibrosis with a somatostatin agonist
Infobox
Is a
Patent jurisdiction
Patent number
07238666
Date of patent
July 3, 2007
Patent application number
10935593
Date Filed
September 7, 2004
Patent primary examiner
Find more entities like US Patent 7238666 Method of inhibiting fibrosis with a somatostatin agonist
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.